Interview with the Innovators

Supported by BridgeBio

Transthyretin (TTR) Amyloidosis: Disease Definition and Key Clinical Features

Ola Akinboboye, MD, MPH, MBA
Clinical Professor, Cardiology
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell & Medical Director
Laurelton Heart Specialists PC
Rosedale, NY
Ola Akinboboye, MD, MPH, MBA, Clinical Professor, Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health and Medical Director, Laurelton Heart Specialists PC (Rosedale, NY) describes the clinical manifestations of wild-type and hereditary or variant transthyretin amyloidosis (ATTR) and some common mutational drivers of pathogenic phenotypes.

Related Items

Amyloidosis News
Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News by subscribing to receive the free AMN e‑Newsletter.